Skin Elements (ASX:SKN) Ending Cash Position: A$0.84 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Skin Elements Ending Cash Position?

Skin Elements ASX:SKN Ending Cash Position is A$0.84 Mil as of Jun. 2026. The stock has 3 warning signs investors should review.

Skin Elements's Ending Cash Position for the quarter that ended in Jun. 2026 was A$0.84 Mil.

Skin Elements's quarterly Ending Cash Position increased from Jun. 2025 (A$0.06 Mil) to Dec. 2025 (A$1.73 Mil) but then declined from Dec. 2025 (A$1.73 Mil) to Jun. 2026 (A$0.84 Mil).

Skin Elements's annual Ending Cash Position declined from Jun. 2024 (A$0.14 Mil) to Jun. 2025 (A$0.06 Mil) but then increased from Jun. 2025 (A$0.06 Mil) to Jun. 2026 (A$0.84 Mil).

Skin Elements Ending Cash Position Related Terms

Skin Elements Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Skin Elements's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Skin Elements Ending Cash Position Chart

Skin Elements Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25 Jun26
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.75 0.36 0.14 0.06 0.84

Skin Elements Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.06 0.06 1.73 0.84

Skin Elements Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Skin Elements's Ending Cash Position for the fiscal year that ended in Jun. 2026 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.06+0.78
=0.84

Skin Elements's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=1.733+-0.893
=0.84

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of A$0.84 Mil mean?
Skin Elements (ASX:SKN) has a Ending Cash Position of A$0.84 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Skin Elements and its competitors.
Is Skin Elements' Ending Cash Position too high?
Skin Elements' current Ending Cash Position is A$0.84 Mil.
How does Skin Elements' Ending Cash Position compare to PG and CL?
Skin Elements' Ending Cash Position of A$0.84 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Consumer Packaged Goods company?
A good Ending Cash Position depends on the Consumer Packaged Goods industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Skin Elements and its competitors. Skin Elements's current Ending Cash Position is A$0.84 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Skin Elements stock overvalued right now?
Skin Elements (ASX:SKN) has a current Ending Cash Position of A$0.84 Mil. The current Ending Cash Position is A$0.84 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Skin Elements (ASX:SKN), the current Ending Cash Position is A$0.84 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Skin Elements Business Description

Address 1255A Hay Street, West Perth, Perth, WA, AUS, 6005
Skin Elements Ltd is a company that operates in the beauty and personal care industry. The principal business activities include the manufacture and distribution of natural, organic, health, and wellness products. Its brand portfolio includes Soleo Organics natural sunscreen brand, the PapayaActivs therapeutic skincare range, Elizabeth Jane Natural Cosmetics, and the recently developed Invisi-Shield SuprCuvr plant-based hospital-grade disinfectant range. The company has a single segment being research and development of the inventive proprietary SE Formula biotechnology.